Glenmark Pharmaceuticals Ltd., a research-led, global pharmaceutical company, today announced the initiation of a multi-country (ex-China) Phase 3 Clinical Trial for Envafolimab, a novel subcutaneous PD-L1 inhibitor, in patients with resectable Stage III Non-Small Cell Lung Cancer (NSCLC) in the neoadjuvant/adjuvant setting. The Company has received approval from the Drugs Controller General of India (DCGI) […]
Early diagnosis saves Bengaluru man’s life with lung cancer through advanced procedures
When 52-year-old Rahul (name altered), a non-smoker and fitness enthusiast, started experiencing a persistent cough, he initially thought it was a seasonal allergy. But after months, the cough persisted, and he noticed breathlessness while climbing stairs. A CT scan showed a localised lesion in the right upper lobe of his lung, raising concerns that something […]